Launch of the European project RISK-HUNT3R The new Horizon 2020 project RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs was launched on 1 June.
Effects of COVID-19 vaccination becoming increasingly visible In the past calendar week, there were 43% fewer hospital admissions of patients with COVID-19 compared to the week before.
People born in 1981 invited for COVID-19 vaccination As of today, people born in 1981 can schedule an appointment online via www.coronavaccinatie-afspraak.nl for vaccination by the Municipal Public Health Services (GGDs).
Number of COVID-19 infections continues to increase 1,329 new COVID-19 infections were reported over the past week. That is 342 more confirmed cases reported than the week before that, when 987 new COVID-19 infections were reported.
Number of COVID-19 infections is increasing 987 new COVID-19 infections were reported over the past week. This is nearly twice the number of infections reported in the previous week, when 534 new cases were reported.
Gap between intention and behaviour in staying home and testing for COVID-19 The Dutch policy of staying home and getting tested if you have corona-related symptoms can count on support from the majority of the over 50,000 participants in RIVM’s behavioural study.
About 100 COVID-19 infections detected per week through source and contact tracing The results of 14 days of monitoring of source and contact tracing are known for week 26 (22 to 28 June).
Building blocks for a definition of microplastics The Dutch National Institute for Public Health and the Environment, RIVM has described building blocks for a definition of microplastics.
Jacco Wallinga appointed extraordinary Professor at LUMC From 1 September, Jacco Wallinga will hold the chair in Mathematical Modelling of Infectious Diseases at the department of Medical Statistics and Bio-informatics of the Leiden University Medical Ce
Little incentive from pharmaceutical legislation to promote alternatives to animal testing Current pharmaceutical legislation does not impose any legal constraints on the use of alternatives to animal testing, but neither does it actively encourage the use of these alternatives.